Alimera Sciences reported $-3411000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Aerie Pharmaceuticals AERI:US USD -26672000 8.54M
Alimera Sciences ALIM:US USD -3411000 1.44M
Applied Genetic Technologies AGTC:US USD -17344000 380K
Bayer BAYN:GR EUR 1.2B 1.03B
Insmed INSM:US USD -127697000 39.38M
Novartis NOVN:VX USD 2.17B 60M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M